Introduction ! Percutaneous puncture of an intrahepatic portal or intrasplenic vein is an option for accessing the portal vein, e. g. in order to treat portal vein stenosis or thrombosis [1 -8] . After the intervention removal of the inserted catheter or sheath can result in significant bleeding from the puncture tract which might necessitate emergent surgery. Embolization of the transparenchymal puncture tract using various embolic agents including collagen, coils, Gelfoam, and N-butyl cyanoacrylate has been described [1 -8] .
The purpose of the present study was to report on first results of embolization of large bore and/or short transhepatic and transsplenic puncture tracts using Amplatzer Vascular Plugs (AVP).
Patients and Methods

! Patients
The Independent Ethics Committee at the University Medical Center of Regensburg confirmed that according to the state law for retrospective studies such as this, ethics approval or the committee's opinion is not necessary. In February 2011 we started to use AVPs (AGA Medical Corp., North Plymouth, Minnesota, USA) for the embolization of transhepatic and transsplenic puncture tracts. All patients in whom embolization of those transhepatic or transsplenic puncture tracts with AVP was attempted were retrospectively analyzed. Embolization with an AVP was attempted in 5 patients (3 females; age range: 3 -71 years). The medical records as well as the radiological reports and images of these patients were evaluated.
Patient characteristics are presented in • " Table 1 . Two patients (patients # 1 and # 2) presented with stenosis and three patients (patients # 3 -5) with thrombosis of the portal vein. It was decided to treat these conditions by a percutaneous transhepatic or transsplenic approach in interdisciplinary consensus. Written informed consent was obtained from the patients and the parents of patient # 5.
Portal vein intervention
Based on the findings of contrast-enhanced computed tomography of the abdomen which was performed prior to each intervention, it was decided to access the portal vein by a transhepatic and a transsplenic approach in four patients (patients # 1 -4) and one patient (patient # 5), respectively. In the latter case (patient # 5), computed tomography displayed extensive thrombosis of the splenic vein as well as some thrombi within the portal vein ( • " Fig. 1 ). In this patient a left-lateral-segment liver graft was implanted orthotopically. The course of the extrahepatic portal vein took a 145 degree curve to the left ( • " Fig. 1b ). Hence, it was determined that thrombus aspiration via a transsplenic access was more suitable than via a transhepatic access.
In each patient an attempt was made to puncture a peripheral branch of the right portal vein or a peripheral intrasplenic vein about 2 -3 cm (in children 1 -1.5 cm) central to the liver or spleen capsule under sonographic guidance using a 21-gauge needle (CHIBA, Boston Scientific, Natick, MA, USA). A guide wire was advanced into the portal or splenic vein, and, using an Accu-Stick introducer system (Boston Scientific, Natick, MA, USA), a sheath was inserted in the Seldinger technique. In two patients (patients # 1 and # 2) stenting of a portal vein stenosis was carried out ( • " Table 1 ). In three patients (patients # 3 -5) thrombus aspiration in combination with thrombolysis for five to eight days was performed. For these treatments 6 to 10 French sheaths were inserted ( • " Table 1 ). In patients # 1 and # 2 5000 IU of heparin were administered peri-interventionally. In patients # 3 -5 thrombolysis was performed using urokinase (30 000 IU per hour) in combination with continuous heparin infusion (partial thromboplastin time, 80 -100 s). Patient # 5 was given aspirin (50 mg per day) as well. In patients # 3 -5 administration of urokinase and heparin was ceased for 2 hours prior to embolization of the puncture tract.
Indication for use of AVP
After treatment of the portal vein was completed, embolization of the transhepatic and transsplenic puncture tracts using an AVP was carried out by three operators with 3 -15 years interventional radiology experience. Due to reported bleeding complications which emerged despite embolization of the puncture tracts using various embolic agents, the interventionists considered AVPs to be the most favorable agent for effective, safe and quick embolization of the relatively large bore puncture tracts in all five cases. In addition, in patient # 5, a 3-year old boy, it was considered that the use of an AVP might allow embolization of the relatively short transsplenic puncture tract safely and precisely at a subcapsular site. According to the interventionists' preference, AVP II or AVP IV was used.
Technique of puncture tract embolization.
In three patients (patients # 1, # 3, and # 5) the puncture tract was embolized by the same operator who attempted to place the AVP II within the puncture tract in the manner that the distance between the AVP and the hepatic or splenic capsule was 1.5 cm and 1 cm in adults and children, respectively ( • " Fig. 1 , 2).
Embolization of patients # 2 and # 4 was performed by two other operators who attempted to place an AVP II or AVP IV in the middle portion of the puncture tract ( • " Fig. 3, 4) . In three patients a stiff guide wire (patient # 1, 0.014-inch PT2-wire, Boston Scientific Corporation, Natick, MA, USA, • " Fig. 2 ; patients # 3 and # 5, 0.035-inch Amplatz Guidewire, Boston Scientific Corporation, Natick, MA, USA, • " Fig. 1 ) was placed in the portal vein as a lock wire in order to enable reinsertion of the sheath into the puncture tract in case the sheath accidentally dislocated from the puncture tract. In patients # 1, # 2, and # 4 the AVP was positioned within the tip of the sheath. Then the sheath was pulled back carefully. Contrast medium was injected through the sheath to document the position of the tip of the sheath within the portal or splenic vein or the transparenchymal puncture tract. Contrast medium that extended to the central veins or through the puncture tract to the perihepatic or perisplenic space helped to determine the position of the sheath within the puncture tract, in particular to determine the distance between the tip of the sheath and the hepatic or splenic capsule. After suiting the AVP at the intended closure site, the sheath was pulled back while fixing the AVP in position. Contrast medium was injected through the sheath to verify the correct position of the AVP. Then the AVP was released and the lock wire (patients # 1, # 3, and # 5) and the sheath were carefully removed. In patients # 3 and # 5 a 6 French guiding catheter (Guider Softip, Boston Scientific, Plymouth, MN, USA) was used in addition for precise AVP placement. The AVP-loaded catheter was placed in the central part of the liver or spleen. The sheath was pulled back until the tip of the sheath was suited at a subcapsular position about 1 cm medial to the hepatic or splenic capsule. The guiding catheter was pulled back and the AVP was released at the intended closure site. To enable precise AVP placement, the C-arm of the angiography unit was positioned so that the view direction was orthogonal to the transparenchymal puncture tract. In patient # 5, sonography was used in addition to fluoroscopy to control the placement of the AVP. The AVP was clearly visible on ultrasound as a strongly echogenic object within the subcapsular intrasplenic puncture tract. Using both fluoroscopic as well as sonographic guidance helped to determine the definite position of the AVP within the puncture tract. After removal of the sheath, a patch was applied to the cutaneous puncture site. Ten minutes later sonography of the upper abdomen was performed to rule out bleeding. Four hours later another sonographic control and control of the hemoglobin level were carried out. Peri-interventional antimicrobial therapy was given in patients # 3 and # 5. Fig. 1 3-year-old boy (patient # 5) with biliary atresia, status post orthotopic transplantation of a left-lateral-segment liver graft, and currently secondary sclerosing cholangitis, portal hypertension and splenomegaly. a Coronal reconstruction of contrast-enhanced computed tomography displayed extensive thrombosis of the splenic vein (delineated by arrows) as well as some thrombi within the portal vein (not shown). K, left kidney; S, stomach. b Despite heparin therapy, the thrombosis was progressive sonographically and ascites was accumulating. Hence, two days after computed tomography percutaneous intervention was carried out. The tip of an Accustick Introducer system (asterisk; Boston Scientific, Natick, MA, USA) was placed within an intrasplenic vein via transsplenic access. After contrast material injection via the introducer system, the splenic vein (SV) as well as the proximal part of the portal vein (PV) were patent without identifiable residual thrombi. However, the distal part of the portal vein (its course is displayed by arrows) was not contrasted due to extensive thrombi which might have moved from the splenic vein to this site. SMV, superior mesenteric vein. c After transsplenic thrombus aspiration and thrombolysis, the transsplenic puncture tract was embolized using an Amplatzer Vascular Plug II (diameter, 4 mm; arrows). Asterisk, tip of sheath; curved arrow, lock wire; T, ultrasound transducer. 
Follow up !
The medical records were evaluated to assess the technical and clinical success of the puncture tract embolization and to assess local or systemic complications related to AVP placement (e. g., drop of hemoglobin level, infection, hepatic or splenic infarction, AVP dislocation). To evaluate follow-up of discharged patients, the patients' general practitioners were called by telephone. Fig. 2 70-year-old female (patient # 1) with biliary cirrhosis and status post liver transplantation. a After percutaneous transhepatic access to the portal vein system, the tip of a sheath was placed in the cranial part of the superior mesenteric vein (SMV Fig. 3 63-year-old male (patient # 4) with status post hypernephroma and extensive portal vein thrombosis. a After percutaneous transhepatic access to the portal vein system, the tip of a catheter was positioned in the cranial part of the superior mesenteric vein (SMV). After contrast material injection via the catheter, digital subtraction angiography displayed thrombi within the SMV (arrows) as well as non-enhancement of the main portal vein due to thrombotic occlusion. In addition, digital subtraction angiography showed several faintly contrasted venous collateral channels around the main portal vein (arrowheads) as a correlate of cavernous transformation of the portal vein. Asterisk, tip of the sheath within the portal vein. b After percutaneous thrombus aspiration and thrombolysis digital subtraction angiography demonstrated a patent SMV (arrows) as well as a patent main portal vein with residual wall-adherent thrombi (arrowheads). c The transhepatic puncture tract was embolized using an Amplatzer Vascular Plug (AVP) II (diameter, 8 mm; arrows). After contrast material injection via the sheath (asterisk, tip of sheath) posterior-anterior digital subtraction angiography demonstrated brisk opacification of a hepatic vein (curved arrows) providing evidence for a fistula between the puncture tract lateral to the implanted AVP II and a hepatic vein. Arrowheads, lateral portion of the puncture tract. C, contrast material extending to the adjacent hepatic parenchyma. d A second AVP II (diameter, 6 mm; black arrowhead) was inserted into the intrahepatic puncture tract lateral to the fistula. Asterisk, delivery wire of the AVP II; arrows, primarily implanted AVP. e A contrastenhanced computed tomography delineates the position of the AVPs II within the liver (L). The distance between the lateral edge of the primarily implanted AVP II (arrows) and the liver capsule was 3.3 cm. Arrowhead, secondarily inserted AVP II. PV, portal vein. 
Results
!
Stenting of portal vein stenoses (patients # 1 and # 2) as well as thrombus aspiration and thrombolysis of portal vein thrombosis (patients # 3 -5) were carried out technically successfully (residual stenosis < 30 %) in all five patients. In three cases the transhepatic or transsplenic puncture tract was embolized by using one AVP II (diameter, 4 mm; patients # 1, # 3, # 5; • " Fig. 1, 2) , in one case by using one AVP IV (patient # 2; • " Fig. 4 ), and in one case (patient # 4) by using two AVPs II (diameter, 8 and 6 mm;
• " Fig. 3 ). In the latter patient (patient # 4) a fistula between the puncture tract lateral to the primarily implanted AVP II (diameter, 8 mm) and a hepatic vein was identified by contrast material injection. Hence, a second AVP II (diameter, 6 mm) was placed within the intrahepatic puncture tract lateral to the fistula. In all patients embolization with an AVP was relatively easy and fast to perform and technically successful. There was no case of immediate post-interventional bleeding, bleeding from the puncture site during follow-up or dislocation of the AVP. During a median follow-up of 14 months (range, 21 days to 21 months), there was one complication related to AVP placement: six days after embolization of the transhepatic puncture tract with an AVP IV, patient # 2 presented at the institutional emergency department with jaundice (total serum bilirubin: 12.4 mg/dl) as well as increased serum C-reactive protein (15.3 mg/dl). Three days later contrast-enhanced computed tomography depicted a focal hypodense liver lesion around the AVP ( • " Fig. 4a ). Microbiolo-gical testing of fluid aspirated from the lesion confirmed a liver abscess with beta-hemolytic streptococci. By antimicrobial therapy (Amoxicillin 50 mg and Clavulanic acid 125 mg, 1 -0-1, 15 days) as well as percutaneous drainage of the abscess for one week, the abscess was successfully treated. Contrast-enhanced computed tomography performed two months after AVP placement revealed complete resolution of the abscess ( • " Fig. 4b ).
In patients # 1 -4 follow-up computed tomography scans of the upper abdomen were carried out for other reasons. The distance between the lateral edge of the AVP and the liver capsule was 1.3 cm, 3.5 cm and 1.2 cm in patients # 1, # 2 and # 3, respectively ( • " Fig. 2, 4) . In patient # 4 the distance between the lateral edge of the AVPs and the liver capsule was 3.3 cm and 0.8 cm for the primarily and secondarily implanted AVPs, respectively ( • " Fig. 3 ). No AVP dislocation was detected.
Discussion
!
The percutaneous transhepatic approach constitutes a widely accepted access to the portal vein system [2, 4, 6]. However, this access is associated with minor complications like transient pain at the puncture site or mild hypotension as result of vasovagal reaction [9] as well as major complications like bleeding, hemobilia, pseudoaneurysms and infection [3, 10] . Bleeding from the puncture tract is usually of a venous origin and most likely a result of Fig. 4 47-year-old female (patient # 2) with metastatic mucinous adenocarcinoma of the appendix presented with portal vein stenosis due to tumor compression. After percutaneous stenting of the portal vein, the intrahepatic puncture tract was embolized using an Amplatzer Vascular Plug (AVP) IV (diameter, 4 mm). a Nine days later contrast-enhanced computed tomography revealed a focal liver abscess (A) adjacent to the AVP (arrows). Curved arrow, air entrapment within the abscess. Arrowheads, augmented fluid retention circular around branches of the portal vein, presumably related to insufficient lymph drainage due to tumorous compression of the lymphatic vessels at the liver hilum. *, stent within the portal vein. x, stents within the common hepatic duct. b After percutaneous drainage of the abscess and antimicrobial therapy, contrast-enhanced computed tomography performed two months after AVP placement revealed complete resolution of the abscess. 
